Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
Afinitor (everolimus): On Friday July 20th 2012 the FDA approved a new drug in the fight against breast cancer. Afinitor (marketed by Novartis Pharmaceuticals Corp.) a drug that has been approved by the FDA to fight advanced kidney and neuroendocrine tumors, has now been approved by the FDA (Food and Drug Administration) to fight an [...]
Avastin, one of the world’s most popular cancer drugs, has been under intense scrutiny by the FDA while the agency works to determine whether or not to pull its approval of the drug as a treatment for breast cancer. In an effort to save one of its best-selling products, the drug’s manufacturer, Roche, has asked [...]
After the drug diethylstilbestrol (DES) was taken off the market, several studies revealed that the medication could potentially cause reproductive tract defects and cancers in girls born to mothers who took the drug during pregnancy. Recently, a group of breast cancer patients have filed suit in a Boston court, claiming their cancers were caused by [...]
Roche’s best-selling cancer drug, Avastin, is currently the subject of an unprecedented hearing set to take place this week. Federal regulators have scrutinized the once-promising drug after it proved to carry more risks than benefits in patients taking the medication as a treatment for breast cancer. In fact, the U.S. Food and Drug Administration granted [...]
